ACAP1 and glioblastoma: The DSS analysis in TCGA demonstrated that patients with low ACAP1 levels possessed significantly worse DSS than those with high ACAP1 levels in ACC, BLCA, CESC, DLBC, HNSC, LIHC, LUAD, PAAD, SARC, SKCM, UCEC, and UCS but better DSS in GBM and KIRC (Figure S8).